Interleukin-3 (IL-3) regulates growth and differentiation of multipotential as well as lineage-committed progenitor cells. The human IL-3 receptor (IL-3R) consists of the a and common j3 (&) subunits. The a subunit (IL-3Ra) is specific for IL-3 and binds IL-3 with low affinity. In contrast, the 8, subunit does not bind any cytokine by itself, but forms a high-affinity receptor with IL-3Ra. As the same j3, subunit also forms high-affinity receptors for IL-5 and granulocytemacrophage colony-stimulating factor (GM-CSF) with the respective cytokine-specific a subunit, the expression of the a subunits is responsible for specificity of cytokines. To examine the expression of IL-3Ra. we have developed a monoclonal antibody (MoAb), N3A. N3A specifically bound to cells expressing IL-3Ra and immunoprecipitated a 75 Kd glycoprotein, which became 43 Kd on N-glycosidase digestion. N3A and an anti-& antibody, CRSl , were used in double color fluorescence-activated cell sorter (FACS) staining with several lineage markers to see the IL-3R expression pattern in peripheral blood (PB), cord blood (CB), and bone marrow (BM) cells. Both IL-3R subunits were expressed on myeloid cell lineages (CD13+,
EMATOPOIETIC CELLS of various lineages are de-
H rived from a pluripotent hematopoietic stem cell.
Human interleukin-3 (IL-3) supports proliferation and differentiation of myeloid cells including megakaryocytes, eosinophils, basophils, monocytes, granulocytes, and erythroid progenitors.'-6 IL-3 interacts with multipotential progenitors and supports the formation of multilineage colonies from a stem cell population enriched by the anti-CD34 antibodies.'-'' IL-3 stimulates growth of some B cells, but not T cells. Some of these IL-3 functions are similar to the activities exhibited by granulocyte-macrophage colonystimulating factor (GM-CSF) and IL-5. For example, the formation of granulocyte and monocyte colonies is induced by either IL-3 or GM-CSF and the development of eosinophils is supported, at least in vitro, by either IL-3, IL-5, or GM-CSF. The pattern of tyrosine phosphorylation induced by IL-3, IL-5, and GM-CSF are similar.''-'3 Although there is no significant amino acid sequence homology among IL-0 7993 by The American Society of Hematology.
3, IL-5, and GM-CSF, they compete with each other for binding to their high-affinity receptors (cross-competit i~n ) .~J " '~ Molecular cloning of the receptor subunits and reconstitution ofthe high-affinity receptors have provided a molecular basis for common biologic functions as well as signals induced by distinct cytokines: High-affinity receptors for IL-3, IL-5, and GM-CSF consist of two subunits, a and (3c.20-22 Each cytokine has its specific a subunit (IL-3Rq IL-SRa, and GM-CSFRa), which binds the respective cytokine with low-affinity. These a subunits are members of the hematopoietic cytokine receptor family and have a small intracellular domain with a common motif.21 In contrast to the a subunits, only one type of @ subunit (common / 3 or ( 3, ) is present in the human IL-3, IL-5, and GM-CSF receptors. The (3, subunit does not bind any cytokine by itself, but forms high-affinity receptors for IL-3, IL-5, and GM-CSF with a respective a subunit. Because (3, is cross-linked with these cytokines when the high-affinity receptors are formed, the (3, subunit is also considered as a binding component. The (3, subunit has two repeats of the common motif of the hematopoietic cytokine receptors in the extracellular domain and has a large intracellular domain without known sequence of signaling molecules such as kinases. Because the (3, subunit is an essential component for signal transduccommon functions of IL-3, IL-5, and GM-CSF appear to be mediated by the @, subunit and the expression of an a subunit is responsible for the specificity to cytokines.
However, it has not been proven yet whether all the functions of IL-3 are mediated by the same high-affinity receptor composed of IL-3Ra and &, because IL-3 interacts with various types of cells including multipotential hematopoietic cells. In addition, function of IL-3 on early hematopoietic cells is known to be enhanced by other cytokines including IL-1, IL-6, G-CSF, stem cell factor (SCF), interferon (IF")--, or tumor necrosis factor (TNF)-a25-32 and upregulation of the IL-3R by IL-1 was found in certain hematopoietic ~e l l s .~~,~~ Therefore, it is important to examine the expression of the IL-3R subunits on various types of hematopoietic cells. Because the binding affinity of hIL-3 to the human IL-3R a subunit is extremely low (kd -100 nmol/L), it is difficult to detect the IL-3R a subunit expression by IL-3 binding. Therefore, we have generated a MoAb (N3A) against IL-3Ra to detect the a subunit. UsingN3A in combination with the MoAb against p, (CRSl), which we generated previously,34 we have investigated the cellular distribution of the IL-3R subunits in human peripheral blood (PB), bone marrow (BM), and cord blood (CB) cells. We also studied the IL-3R expression on CD34' hematopoietic progenitor cells and its modulation by cytokines.
MATERIALS AND METHODS
Cell lines. media, and cytokines. The human cell lines KG 1 and EOL3 were cultured in RPMI 1640 supplemented with 10% fetal calf serum (FCS), 100 U/mL penicillin, and 100 pg/mL streptomycin. The factor-dependent cell line TF13' and M07E36 were cultured in RPMI 1640 containing 10% FCS, 2 ng/mL of hCM-CSF, or 5 ng/mL of hIL-3, respectively. The murine cell line Ba/F337 and CTLL238 were cultured in RPMI 1640 containing 10% FCS, 100 U/mL of mIL-3, or 100 U/mL of mIL-2, and 50 pmol/L of 2-mercaptoethanol (2-ME), respectively. NIH3T3 was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS, 100 U/mL penicillin and 100 pg/mL streptomycin. Transfectants expressing the receptor subunits were cultured in the presence of either 0.5 mg/mL G418 or 0.5 mg/mL hygromycin depending on the selection marker used to establish the transfectants as previously described. 39 Recombinant hGM-CSF produced in Escherichia coli was provided by Dr R. Kastelein (DNAX, Palo Alto, CA) and hIL-3 produced in E coli was purchased from R&D systems (Minneapolis, MN). Recombinant hC-CSF was provided by Dr N. Arai (DNAX) and hIL-6, hIL-la, hTNF-a, and c-kit ligand were purchased from Genzyme (Cambridge, MA). Recombinant hIFN-y and hTGF-P were purchased from Amersham (Arlington Heights, IL) and Oncomembrane (Seattle, WA), respectively. Mouse IL-3 was produced in silkwormN and mIL-2 produced in E coli was provided by Dr G. Zurawski (DNAX). Fractionation ofperipheral blood, cord blood, and bone marrow cells. BM, PB, and umbilical CB samples were collected according to institutional guidelines. Blood was collected in glass vessels containing preservative-free grade-1 sodium heparin (Sigma, St Louis, MO) at a final concentration of 20 IU/mL. Light-density mononuclear cells were isolated by Ficoll-Hypaque (Eurobio; Paris, France) gradient-separation at a density of 1.077 g/mL. Mononuclear fractions were depleted of adherent cells by incubation at 37°C with RPMI I640 containing 1 % wt/vol tissue-culture grade bovine serum albumin (BSA; Boehringer, Mannheim, Germany). Cells bearing the CD34 antigen were isolated from nonadherent mononuclear fractions through positive selection by panning using anti-CD34 antibody (IMU. 133-3; Immunotech, Marseilles, France). After overnight incubation at 37°C with complete media (RPMI 1640 supplemented with 10% FCS, 100 U/mL penicillin, 100 pg/ mL streptomycin, 50 pmol/L 2-ME, and 10 mmol/L HEPES), second step purification was performed using a cocktail of MoAbs, Leu-M3 (CD 14), Leu5b (CD2), Leu3 (CD4), Leu 1 1 a (CD 16), and Leu16 (CD20), (Becton Dickinson, San Jose, CA) and immunomagnetic beads (Dynabeads M450; Dynal, Olso, Norway), as described previou~ly.~' The CD34' cells thus isolated were greater than 95% pure.
Anti hIL-3Ra MoAb. Balb/c mice were immunized on day 0 with IO' cells of Ba/F3-a emulsified in Complete Freund's adjuvant in the hind foot pad. On day 3 and day 10 the mice were boosted with lo7 cells of Ba/F3-a in phosphate-buffered saline (PBS) in the same foot pad. On day 1 1, the regional lymph nodes were removed and the cells were fused with the mouse myeloma cell line P3X63Ag8.653 at a 1: 1 ratio with 50% polyethylene glycol by standard fusion procedures. HAT-resistant cells were selected as des~ribed.~' Supernatants of hybridomas were screened by fluorescence-activated cell sorter (FACS) using stable transfectants expressing IL-3Ra. The hybridoma cells secreting MoAb (N3A) that stained the IL-3Ra expressing transfectants but not parental cells were recloned by limiting dilution.
Ascites fluid was obtained by injecting the N3A producing cells in pristane-treated nu/nu Balb/C mice. MoAb was purified from ascites fluid by protein-A Sepharose (Pierce, Rockford, IL) as described by the manufacturer. Antibody subclass was determined using a Monoclonal typing kit (ICN, Irvine, CA) as described by the manufacturer.
Other antibodies. Anti+,, CRS 1, was generated as described previo~sly.~~ FITC/anti-CD 15, FITC/anti-CD 13, FITC/anti-CD33 Biotinylation qfantihodies. Anti-hlL-3Ra and anti-& antibodies were biotinylated using ENZOTIN (Enzo Biochemicals, Farmingdale, NY) as described by the manufacturer.
Cell staining andjlow cytometry FACScan analvsis. Cells ( I Os to IO6) were incubated with 100 pL ofhybridoma supernatant or an appropriate amount of purified MoAb (0.1 to IO pglmL) in the staining buffer (PBS containing 0.02% of sodium azide and 2% FCS) for 1 hour at 4°C. Cells were washed twice and resuspended in the staining buffer containing an appropriate dilution of fluorescein isothiocyanate (FITC)-conjugated second antibody and incubated for 30 to 60 minutes at 4°C. Cells were washed twice and the fluorescence intensity was measured by FACScan (Becton Dickinson). When necessary, propidium iodine was added before analysis to exclude nonviable cells. Double-color membrane fluorescence was performed as follows: cells incubated with unconjugated Ab or FITC-conjugated Ab for 30 minutes at 4°C were washed twice and resuspended in 5% mouse serum and incubated for 30 minutes at 4°C. Biotinylated MoAbs were then added to the cell suspension. Cells were then washed twice and incubated with buffer containing streptavidin-PE. Fluorescence intensity was measured with a FACScan instrument (Becton Dickinson).
Immimoprecipitatin. Cells were labeled with [3SS]-Translabel (ICN) as described previously." Cell pellet was resuspended at 2.5 X IO' cells/mL in ice-cold lysis buffer (50 mmol/L Hepes pH 7.5, 100 mmol/L NaCI, I mmol/L EDTA, I mmol/L phenylmethylsulfonylfluoride. I &nL each aprotinin, leupeptin, pepstatin, chymostatin, antipain. and I% Triton X-100). After 20 minutes on ice. antibody per IO' cells) for 2 hours at 4°C. lmmunecomplexes were absorbed to protein A-agarose for I hour at 4°C. The agarose beads were washed 5 times with 0.5 mL of lysis buffer. Proteins eluted by boiling in 2X Laemmli gel sample buffer were electrophoresed on 4% to 20% polyacrylamide gradient/SDS gel. Fluorography was performed using Enlightning (DuPont. Wilmington, DE).
Immunoprecipitates were suspended in the incubation buffer (50 mmol/L sodium phosphate buffer pH 8.0,50 mmol/L EDTA, I% Triton, 1 mmol/L PMSF, I pg/mL aprotinin, leupeptin) and treated with 1 U/mL of N-glycosidase-F at 37°C for 48 hours.
Deglvcosylation.

RESULTS
Hybridomas were generated by fusion of P3X63Ag8.653 with the regional lymph node cells of Balb/c mice immunized with the Ba/F3 transfectant (Ba/F3-a) expressing hIL-3Ra. One out of 48 hybridomas examined secreted the antibody that bound hIL-3Ra-positive cells, such as Ba/F3-a. NIH3T3-a&, and TFI. The MoAb (N3A) produced by this hybridoma was typed as mouse IgG,. The N3A MoAb bound to the hIL3Ra cDNA transfectants including Ba/F3-a, Ba/F3-apC, CTLL2-a, CTLL2-a&, NIH3T3-a, and NIH3T3-a&, but not their parental cell lines (Fig I) . N3A MoAb also bound to human hematopoietic cells that expressed IL-3R as described below.
To further characterize the N3A MoAb. 
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a protein of 75 Kd from the IL-3Ra expressing transfectants, but not from the parental cells (Fig 2A) . The molecular weight was consistent with the molecular size of IL-3Ra estimated from cross-linking experiments. Because the protein band was broad on the reducing SDS-PAGE gel, it appeared to be glycosylated. To test this possibility, the N3A immunoprecipitates were treated with N-glycosidase F. The glycosidase digestion reduced the apparent molecular weight to -43 Kd which is consistent with the molecular weight calculated from the amino acid sequence of hIL-3Ra (Fig 2B) .
IL-3R expression on human cell lines. Anti-hIL-3Ra antibody, N3A, and anti-& antibody, CRSl, were used to examine the IL-3R expression level on several human cell lines, ie, TF1, KG1, EOL3, M07E, and Jurkat. TFl, KGl, EOL3, and M07E are myeloid cell lines that express IL-3R (Fig 3) whereas Jurkat is a human T cell line that does not express IL-3R (data not shown). Because fluorescence intensities of TFl and IG3R transfectants stained with the N3A and CRSl antibodies were well correlated with the number of high-and low-affinity binding sites of ' ' ' I IL-3 (data not shown), it appears likely that fluorescence intensities of N3A and CRSl antibodies reflect the expression levels of the IL-3R subunits. Most of the IL-3R-positive hemopoietic cell lines showed brighter staining patterns with N3A than that with CRSl, indicating that the IL-3Ra expression is higher than the p, expression. This is consistent with the model that cross-competition of cytokine binding to highaffinity receptors occurs by competition among different a subunits for a limiting &.
Cellular distribution of the ILL-3R subunits on normal hematopoietic cells. The light density mononuclear cells were isolated from PB, BM, and CB cells as described in Materials and Methods and stained with either N3A or CRS 1 in combination with various antibodies against lineage markers. Figure 4 shows the double staining patterns on CB cells with several lineage markers including CD3, CD13, CD14, CD15, CD19, and CD33. Total mononuclear cells were subdivided into two populations, R1 and R2 based on side scatter (SSC) and forward scatter (FSC). The RI population is the lymphocyte-enriched fraction and R2 is the monocyte-granulocyte-enriched fraction. Both the IL-3Ra and p, subunits were expressed in myeloid cell types with either CD13, CD14, or CD33 in the R2 population. In the case of CDl5, there are two populations: CDl gHi (CDl5 high expression) and CDISLO (CD15 low expression). The CD 1 SHi cells (which are CD 1 4L") representing granulocytes appeared to be IL-3R a/@ negative. The CD 1 SLO (which are CD 1 qHi) representing monocytes were strongly IL-3R-positive. Similar to the hematopoietic cell lines (Fig 3) , the expression level ofthe IL-3R a subunit was higher than that of bc in both populations. Neither N3A nor CRSl MoAb bound significantly to the CD3+ cells in the R 1 population and some of CD19+ cells expressed IL-3Ra and pc (Fig 4) .
The staining patterns of PB and BM were similar to that of CB (the same staining was performed at least twice with different samples) and we did not recognize any significant difference in cellular distribution of the IL-3Ra and pc subunits among BM, PB, and CB (data not shown).
Because it appears that all the myeloid lineage-committed cells from CB, PB, and BM express both the a and 0 subunits of the IL-3R, we asked whether the early progenitor cells also express the IL-3R subunits. Because early hematopoietic progenitor cells are enriched in the CD34+ fraction, we examined the expression of IL-3R on CD34' cells isolated from CB and BM and typical staining profiles of several different samples are shown in Fig 5. CD34' cells from both CB and BM expressed both IL-3R subunits. Like other hematopoietic cells, the IL-3Ra expression level was higher than the p, expression level. The CD34+ fractions were examined for expression of c-kit, the receptor for stem cell factor. Interestingly, binding of anti-c-kit antibody to CD34+ from CB, but not from BM, showed two intensities (Fig 5) . This c-kit staining profile with two peaks in CB was reproducibly observed in more than eight independent experiments. Double staining with N3A and anti-c-kit antibodies showed that the c-kith' cells express relatively homogeneous and low levels of IL-3Ra and IL-3RP. In contrast, c-kit'" cells show a wide range of intensities (from undetectable to high levels) of IL-3Ra expression and weak expression of IL-3RP (Fig 5B) .
Expression of IL-3R on CD34+ hematopoietic cells. 
Fluorescence intensity (PE)(Loglo)
Effect of' various factors on the IL-3R expression. Because IL-3-dependent proliferation of CD34+ cells is known to be enhanced by other cytokines, including IL-1 a, IL-6, G-CSF, SCF, TNF-a, and IFN-y,'0,25-32 we examined whether the IL-3R subunits expression is modulated by these cytokines. First, CD34+ cells from BM were stained with N3A and CRSl to examine the expression level of IL-3R on day 0 (Fig 6a) . Then cells were incubated in medium with or without IL-la, IL-6, G-CSF, SCF, or TNF-a for 2 days and the IL-3R subunits expression was examined by staining with N3A and CRSl antibodies (Fig 6 b to g ).
Although incubation without any cytokine increased the p, expression level significantly, only TNF-a further increased the expression of pC, whereas IL-6, SCF, G-CSF, and IFN-y (not shown) has almost no effect. Similar results were obtained with a shorter incubation of 1 day. The effect of TNF-a on p, was reproducible and we obtained the same result in four independent experiments. The IL-3Ra expression was affected by only G-CSF. G-CSF increased the IL3Ra expression and the G-CSF-induced upregulation of IL-3Ra was still observed after 6 days incubation. The effect of G-CSF on the IL-3Ra expression on day 2 was also reproducible and we obtained the same result in two independent experiments using either BM or CB.
DISCUSSION
Receptor expression is a prerequisite for response to a cytokine and the structure of the high-affinity receptors for IL-3, GM-CSF, and IL-5 has predicted rather ubiquitous expression of the / 3, subunit and more restricted expression of a subunits in hematopoietic cells. Because the binding affinity of IL-3 to IL-3R a subunit is extremely low (kd - 
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100 nmol/L), it is difficult to detect the IL-3R a subunit expression by the IL-3 binding. To examine the IL-3R expression, we have prepared a MoAb N3A against IL-3R a subunit. With N3A as well as MoAb CRS 1 against PC, which we prepared p r e v i~u s l y ,~~ we have investigated the distribution of each hIL-3R subunit on normal hematopoietic cells. As expected from the broad target cell specificity of IL-3, both IL-3Ra and Pc subunits are expressed on myeloid cells of CD 13+, CD 14+, CD 1 5+(Lo) or CD33+ from BM, CB, and PB. Generally, the expression level of IL-3R was low, especially, the P, expression level was almost at the lower limit of detection by FACS. Although it would be interesting to see whether the IL-3R expression level varies during myeloid differentiation, we were not able to fractionate whole cell population by the IL-3R expression level because of its low level of expression. In contrast to the myeloid lineage, the expression of either a or subunit was under the detection level in T cells. As some activities ofIL-3 have been reported on B
we observed IL-3R expression on some of CD19+ cells (Fig 4) . We also observed that some of CD19+ or CD20' cells in adult PBL or tonsil showed a positive IL-3R staining profile (not shown).
We are particularly interested in the IL-3R expression in early hematopoietic progenitors, because one of the most remarkable activities of IL-3 is to stimulate the multipotential progenitors. We have isolated CD34+ cells from BM and CB and examined the expression of IL-3R subunits. Each hIL-3R subunit was expressed weakly in these populations (Fig 5) . Preliminary FACS-sorting experiments based on the IL-3Ra expression have shown that, whereas cells with CD34+IL-3Ra+ phenotype gave rise to day-7 colonies in the presence of IL-3 but not SCF alone, cells with the CD34'IL3Ra-phenotype failed to form day-7 colonies in the presence of either IL-3 or SCF alone. However, CD34+IL-3Ra-cells formed day-7 colonies in the presence of both IL-3 and SCF. Similarly, IL-3 in combination with TNF-a or IFN-7 by FITC-conjugated second antibody. For a negative control, unrelated MoAbs with the same isotype were used. CD34+ cells isolated from BM were cultured in the absence of factors (b) or in the presence of 100 U/mL of hlL-6 (c), 50 ng/mL of hG-CSF (d), 100 ng/mL of SCF (e), 5 ng/mL of TNF-a (f), or 1 ng/mL of IL-la (9) for 2 days. The IL-3R subunit expression on CD34' cells before incubation is shown in (a).
supported the day-7 colony formation of CD34+IL-3Ra-cells (unpublished observation). Thus, it appears likely that the CD34+IL-3Ra-population represents more primitive progenitors that require a combination of several factors for hematopoietic development. This is in accordance with the concept that development of the earliest progenitor cells require several However, because the CD34' population is heterogeneous with different developmental stages, it is not clear at which stage of the hematopoietic development the IL-3R is expressed. To define the critical time point of the IL-3R surface expression, future studies using a more pure and immature cell p o p~l a t i o n~~-~~ are necessary.
The CD34' population from CB but not from BM was subdivided into c-kitHi and c-kitLa subpopulations. Interestingly, c-kitHi cells express relatively homogeneous and low levels of both IL-3Ra and p,. In contrast, c-kitL" cells show a wide range of intensity of IL-3Ra expression (from undetectable to high levels) and weak expression of b,. The c-kitHi population contains erythroid progenitors whereas the ckitL" compartment represents granulocytic, monocytic, and primitive progenitors (unpublished observations). Thus, it is possible that the 1L-3R expression level could vary among different lineages and developmental stages.
Response to a cytokine is often augmented by other cytokines and receptor upregulation may be a potential mechaFor personal use only. on October 22, 2017. by guest www.bloodjournal.org From nism for the a~gmentation.'~,'~ Preincubation of CD34+ cells with IL-3 enhanced proliferative response to GM-CSF5* and IL-1, IL-6, SCF, G-CSF, TNF-a, and IFN-y have a synergistic effect on IL-3-dependent proliferation of CD34+ Whereas I L 3 , GM-CSF, IL-6, SCF, and IFN-y showed n o effect on the expression of IL-3R subunits, G-CSF and TNF-a were shown to modulate expression of IL-3R in CD34' cells. The IL-3R a subunit expression was increased significantly by G-CSF, suggesting the possibility that G-CSF induces the IL-3R expression. Alternatively, as G-CSF alone has CSF activity, it is possible that G-CSF stimulated proliferation of cells with a high level of hIL-3Ra without directly inducing the IL-3R expression.53 TNF-a clearly enhanced the expression of p subunits in CD34+ cells. We have shown that 24 to 48 hours ofpreincubation of CD34' cells in the presence of TNF-a resulted in a subsequent enhancement of their response to IL-3. In addition, the IL-3-insensitive population from CD34+ cells became sensitive to IL-3 by TNF-w5* Thus, in the case of TNF-a, the upregulation of receptor expression could be one of the mechanisms to enhance IL-3 activity. Previously we have shown that the common p subunit is upregulated by either IL-1 a or TNF-a in a factor-dependent myeloid cell line, TF-1 .33, 34 The enhancing effect of TNF-a on the subunit expression in CD34' cells is consistent with the previous observation with TF-1. However, whereas IL-la clearly upregulates the cell surface expression of p, as well as its mRNA in TF-1 cells,34 IL-la had almost no effect on the expression of a and p subunits in CD34+ cells (Fig 6) . These results suggest that augmentation of the IL-3 response by other cytokines is not always accompanied by upregulation of IL-3R. There might be several mechanisms to enhance IL-3 activity. Perhaps high levels of receptor expression may not be very important for the early stage of progenitors and only a small number of the receptors may need to be occupied by I G 3 to mediate biological function, and the IL-3 response may be augmented at some point in the intracellular signaling pathway.
The structure of the high-affinity receptors for IL-3, GM-CSF, and IL-5 indicates that the expression of a subunits is responsible for the specificity to cytokines. All these three cytokines stimulate eosinophil/basophil lineages. Whereas IL-3 and GM-CSF increase eosinophil precursors, IL-5 is a late-acting factor for eosinophil production. Because the / 3 subunit is shared by the three receptors, the expression of the a subunits may change during the differentiation of eosinophils. Therefore, it would be interesting to compare the expression pattern ofthe three a subunits during hematopoietic differentiation. The N3A antibody would be particularly useful to examine the IL-3R a subunit, because the IL-3R a subunit alone cannot be detected by IL-3 binding. Such a n investigation could be applied not only to hematopoietic cells but also to nonhematopoietic cells, because it has been known that the GM-CSF R and, in some instances, lL3R also are expressed on nonhematopoietic cells."s7
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